Episode
Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases
- Podcast
- Breast Cancer Update
- Published
- Dec 23, 2025
- Duration seconds
- 3614
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/toxicities-associated-with-antibody-drug-conjugates-for-metastatic-breast-cancer-clinical-investigator-perspectives-on-actual-patient-cases/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/breast-cancer-update-757579/toxicities-associated-with-antibody-drug-conjugates-for-metastatic-breast-cancer-clinical-investigator-perspectives-on-actual-patient-cases.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Lisa A Carey from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Rita Nanda from The University of Chicago in Illinois engage in an evidence-based discussion around real-world cases involving common toxicities associated with antibody-drug conjugates in the management of breast cancer. CME information and select publications here .